Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitor..

created a new article

34 w

Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors Therapeutics Market Companies: Growth, Share, Value, Size, and Insights | # Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors Therapeutics Market

Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors Therapeutics Market Companies: Growth, Share, Value, Size, and Insig

The global glycogen synthase kinase 3 beta (GSK-3β) inhibitors therapeutics market size was valued at USD 2.19 billion in 2024 and is projected to reach USD 3.29 billion by 2032, with a CAGR of 5.20% during the forecast period of 2025 to 2032.

Comment

34 w

Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors Therapeutics Market Companies: Growth, Share, Value, Size, and Insig

Language